Table 3.
Logistic regression models for type 2 diabetes in relation to anti-PFDN2 antibodies
| Model adjustments | OR | (95% CI) | p value |
|---|---|---|---|
| Unadjusted model | |||
| Anti-PFDN2 antibody | 1.33 | (1.15, 1.54) | 0.0001 |
| Adjusted model 1: | |||
| Anti-PFDN2 antibody | 1.30 | (1.12, 1.50) | 0.0006 |
| Adjusted model 2: | |||
| Anti-PFDN2 antibody | 1.30 | (1.12, 1.50) | 0.002 |
| SAI heritage | 1.33 | (0.95, 1.87) | 0.10 |
| Adjusted model 3: | |||
| Anti-PFDN2 antibody | 1.27 | (1.09, 1.49) | 0.003 |
| SAI heritage | 1.11 | (0.77, 1.60) | 0.58 |
| BMI | 2.31 | (1.93, 2.76) | <0.0001 |
| Adjusted model 4: | |||
| Anti-PFDN2 antibody | 1.27 | (1.09, 1.49) | 0.003 |
| SAI heritage | 1.08 | (0.75, 1.57) | 0.68 |
| BMI | 2.31 | (1.93, 2.76) | <0.0001 |
| Protective SNP haplotype (rs9268852) | 0.61 | (0.40, 0.93) | 0.02 |
Abbreviations: BMI, body mass index; SAI, Southwest American Indian; SNP, single-nucleotide polymorphism
Models 1–4 are also adjusted for age and sex
Anti-PFDN2 antibody and BMI were standardized to a normal distribution with SD = 1; ORs are given for a one SD difference in antibody level
n =796 with complete data for all variables